The Immunoassay Market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 Bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022

The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors that have shaped the growth dynamics are the advent of covid-19, the geriatric population, and rising awareness around health

With the environment changing and climate change-based diseases and viruses growing in the urban and rural areas, the demand for vaccines is on a rise. The immunoassay market survey explains that the tests of the effectiveness of these vaccines are conducted through immunoassays tests that include the strength of antibodies in the immune system, fuelling the sales of immunoassay testing kits.

Don't Miss Out: Get Your Hands on Our Sample Report to Uncover the Lucrative Immunoassay Market! @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15437

Rising awareness, government research and development programs, and covid-19's spread has collectively flourished the demand for the antibodies testing systems. Hence, it has expanded the immunoassay market share in the global market

This fueled the market’s growth prospects and brought opportunities for the new medical and healthcare market players to come up with the latest technology and integrate it with immunoassay technology. Furthermore, the breakdown of the third covid-19 wave has partially slowed down the growth of the market as the spread is at lower levels

Key Takeaways from Market Study

• The Immunoassay market is expected to increase with a market share of 35.0% in North America.
•  
• Asia Pacific is expected to account for 30% market share during the assessment year.
•  
• By product, reagents and kits accounted for 60% share of total revenue generated of the immunoassay market globally and is anticipated to hold the highest share by 2032, owing to the cost-effective products, fueling the overall sales of immunoassay testing instrument
•  
• EIA/ELISA technology gains the highest traction in the market by technology with a market share of 60% and its growth owing to higher use of it in reducing the assay time for immunoelectrophoretic and immunodiffusion while providing accurate and quantitive results.

Competitive Landscape

New market research report on immunoassay defines the market space as a younger space where there is a space for innovation and technology. The defining factors key players have been the ability to deliver effective and accurate results while making the product more logistics friendly and easy to use.

• Siemens Healthineers has introduced its latest and revised fully automated immunoassay platforms and a comprehensive and disease-specific chart in excess of 100 tests. This enhanced productivity and efficiency while delivering accurate and faster results.
•  
• Biomerieux, with more than 26000 immunoassay systems globally has introduced its R7D programs that covers high medical value applications, increased automation and decentralized testing, flourishing the sales of immunoassay platforms.
•  
• Abbott Laboratories focuses on chia technology and offers an automatic immunoassay analyzer named Abbott prism, delivers effectiveness and enhances productivity.
  
  

Immunoassay Market by Category

By Product, Immunoassay Market is segmented as:

• Reagents & Kits
•  
• Analyzers/Instruments
  • Open-ended Systems
  •  
  • Closed-ended Systems
•  
• Software & Services

By Technology, Immunoassay Market is segmented as:

• Radioimmunoassay (RIA)
•  
• Enzyme Immunoassays (EIA)Rapid Test
  • Chemiluminescence Immunoassays (CLIA)
  •  
  • Fluorescence Immunoassays (FIA)
•  
• Others

By End-use, Immunoassay Market is segmented as:

• Therapeutic Drug Monitoring
•  
• Oncology
•  
• Cardiology
•  
• Endocrinology
•  
• Infectious Disease Testing
•  
• Autoimmune Diseases

By Application, Immunoassay Market is segmented as:

• Hospitals
•  
• Blood Banks
•  
• Clinical Laboratories
•  
• Pharmaceutical and Biotech Companies
•  
• Academic Research Centers
•  
• Others

Have a Look at the Latest Research Reports in Healthcare Domain:

Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033.

Bariatric Surgery Devices Market: The bariatric surgery devices market is growing at a moderate pace with a CAGR of 6.2% during the forecast period 2022 to 2032.

Mammography Market: The global mammography market size is estimated to be worth around US$ 1.7 Billion in 2022. However, with the rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around 6.5% to 9% CAGR between 2022 and 2032, totalling over US$ 3.4 Billion by 2032.